Description
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Cas No. | 1022958-60-6 |
---|---|
Purity | ≥98% |
Formula | C28H35ClN6O3 |
Formula Wt. | 539.08 |
IUPAC Name | (1S,2S,3R,4R)-3-[(5-Chloro-2-{[(7S)-1-methoxy-7-(4-morpholinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}-4-pyrimidinyl)amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide |
Synonym | CEP 28122, CEP28122 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Cheng M., Quail M., et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 11(3):670-79 (2012). PMID: 22203728.
Adenosine antagonist, PDE inhibitor.
JAK1/2/3 inhibitor.
Selective inhibitor of cytochrome P450 1B1 (CYP...
Produced by various marine proteobacteria
Thrombin inhibitor.
STING antagonist
Nitroimidazole; hypoxic modifier and radiosensi...
Impurity of omeprazole
Synthetic catechol; ER agonist, microtubule pol...
Extract containing catechins and flavonoids fou...
Endogenous peptide hormone inolved in gastric e...
Dynamin inhibitor.
ANP analog, cardiomodulatory peptide; NPR-A ago...
CDK9 inhibitor.
EGFR inhibitor.
Phosphodiesterase inhibitor that produces anti-...
α1-adrenergic agonist.
Synthetic non-steroid endocrine disrupter; ER a...
Inhibitor of coronaviruses
AurKB/C inhibitor.